Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Acadia Pharmaceuticals and ACAD stock are in selling mode. The FDA gave a thumbs down on a key drug. The post Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today? appeared first on InvestorPlace . More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now Stock Prodigy Who Found NIO at $2… Says Buy THIS Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.